Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Leblond

Showing results (131-140 of 167) with videos related to

Pageof 17
Sort By:
Leukemia & Lymphoma|May 26, 1999
Intensive chemotherapy with hematopoietic cell transplantation after ESHAP therapy for relapsed or refractory non-Hodgkin's lymphoma. Results of a single-centre study of 65 patientsC Soussain, B Souleau, J Gabarre, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2000
Feasibility of tandem autologous stem-cell transplantation (ASCT) in induction failure or very unfavorable (UF) relapse from Hodgkin's disease (HD). SFGM/GELA Study GroupP Brice, M Divine, D Simon, et al.
Blood|October 27, 1998
Anti-B-cell monoclonal antibody treatment of severe posttransplant B-lymphoproliferative disorder: prognostic factors and long-term outcomeM Benkerrou, J P Jais, V Leblond, et al.
Leukemia|November 21, 1998
Autologous hematopoietic stem cell transplantation as salvage treatment for advanced B cell chronic lymphocytic leukemiaL Sutton, K Maloum, H Gonzalez, et al.
Journal of Neuro-Oncology|August 15, 2015
Prevalence of hepatitis B virus in primary central nervous system lymphomaG Faivre, V Thibault, M L Tanguy, et al.
Hematology and Cell Therapy|April 1, 1996
Timed sequential chemotherapy for advanced acute myeloid leukemiaE Archimbaud, V Leblond, P Fenaux, et al.
Blood|March 1, 1996
Expression of p13MTCP1 is restricted to mature T-cell proliferations with t(X;14) translocationsA Madani, V Choukroun, J Soulier, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|August 16, 2011
Effectiveness of second-line treatment in AL amyloidosis patient's refractory to M-DexA Penot, J Abraham, H Debarri, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 10, 2014
Emergence of echinocandin-resistant Candida spp. in a hospital setting: a consequence of 10 years of increasing use of antifungal therapy?A Fekkar, E Dannaoui, I Meyer, et al.
Bone Marrow Transplantation|January 7, 1998
Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia in first remission: long-term results for 42 patients conditioned with an intensified regimen (TBI, high-dose Ara-C and melphalan)E Deconinck, J Y Cahn, N Milpied, et al.
Pageof 17

Showing results (131-140 of 167) with videos related to

Sort By:
Pageof 17
Leukemia & Lymphoma|May 26, 1999
Intensive chemotherapy with hematopoietic cell transplantation after ESHAP therapy for relapsed or refractory non-Hodgkin's lymphoma. Results of a single-centre study of 65 patientsC Soussain, B Souleau, J Gabarre, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2000
Feasibility of tandem autologous stem-cell transplantation (ASCT) in induction failure or very unfavorable (UF) relapse from Hodgkin's disease (HD). SFGM/GELA Study GroupP Brice, M Divine, D Simon, et al.
Blood|October 27, 1998
Anti-B-cell monoclonal antibody treatment of severe posttransplant B-lymphoproliferative disorder: prognostic factors and long-term outcomeM Benkerrou, J P Jais, V Leblond, et al.
Leukemia|November 21, 1998
Autologous hematopoietic stem cell transplantation as salvage treatment for advanced B cell chronic lymphocytic leukemiaL Sutton, K Maloum, H Gonzalez, et al.
Journal of Neuro-Oncology|August 15, 2015
Prevalence of hepatitis B virus in primary central nervous system lymphomaG Faivre, V Thibault, M L Tanguy, et al.
Hematology and Cell Therapy|April 1, 1996
Timed sequential chemotherapy for advanced acute myeloid leukemiaE Archimbaud, V Leblond, P Fenaux, et al.
Blood|March 1, 1996
Expression of p13MTCP1 is restricted to mature T-cell proliferations with t(X;14) translocationsA Madani, V Choukroun, J Soulier, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|August 16, 2011
Effectiveness of second-line treatment in AL amyloidosis patient's refractory to M-DexA Penot, J Abraham, H Debarri, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 10, 2014
Emergence of echinocandin-resistant Candida spp. in a hospital setting: a consequence of 10 years of increasing use of antifungal therapy?A Fekkar, E Dannaoui, I Meyer, et al.
Bone Marrow Transplantation|January 7, 1998
Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia in first remission: long-term results for 42 patients conditioned with an intensified regimen (TBI, high-dose Ara-C and melphalan)E Deconinck, J Y Cahn, N Milpied, et al.
Pageof 17